These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2888096

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 1-(2-Pyrimidinyl)-piperazine as active metabolite of buspirone in man and rat.
    Caccia S, Conti I, Viganò G, Garattini S.
    Pharmacology; 1986; 33(1):46-51. PubMed ID: 2874572
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Disposition of the psychotropic drugs buspirone, MJ-13805 and piribedil, and of their common active metabolite 1-(2-pyrimidinyl)-piperazine in the rat.
    Caccia S, Fong MH, Guiso G.
    Xenobiotica; 1985 Oct; 15(10):835-44. PubMed ID: 2866634
    [Abstract] [Full Text] [Related]

  • 5. The relationship between buspirone bioavailability and dose in healthy subjects.
    Gammans RE, Mayol RF, Mackenthun AV, Sokya LF.
    Biopharm Drug Dispos; 1985 Oct; 6(2):139-45. PubMed ID: 2860931
    [Abstract] [Full Text] [Related]

  • 6. Buspirone, a novel nonbenzodiazepine anxiolytic.
    Kastenholz KV, Crismon ML.
    Clin Pharm; 1984 Oct; 3(6):600-7. PubMed ID: 6150781
    [Abstract] [Full Text] [Related]

  • 7. Buspirone: a new type of anxiolytic.
    Dommisse CS, DeVane CL.
    Drug Intell Clin Pharm; 1985 Sep; 19(9):624-8. PubMed ID: 2864225
    [Abstract] [Full Text] [Related]

  • 8. Disposition and metabolism of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in the rat.
    Caccia S, Muglia M, Mancinelli A, Garattini S.
    Xenobiotica; 1983 Mar; 13(3):147-53. PubMed ID: 6613160
    [Abstract] [Full Text] [Related]

  • 9. Influence of repeated administration of cimetidine on the pharmacokinetics and pharmacodynamics of adinazolam in healthy subjects.
    Hulhoven R, Desager JP, Cox S, Harvengt C.
    Eur J Clin Pharmacol; 1988 Mar; 35(1):59-64. PubMed ID: 3220095
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of the novel anxiolytic drug deramciclane on the pharmacokinetics and pharmacodynamics of the CYP3A4 probe drug buspirone.
    Laine K, Ahokoski O, Huupponen R, Hänninen J, Palovaara S, Ruuskanen J, Björklund H, Anttila M, Rouru J.
    Eur J Clin Pharmacol; 2003 Dec; 59(10):761-6. PubMed ID: 14566442
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of buspirone following oral administration to rhesus monkeys.
    Marathe PH, Shen F, Markham P, Greene DS.
    J Pharm Pharmacol; 1999 May; 51(5):601-7. PubMed ID: 10411220
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative behavioural profiles of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in the murine elevated plus-maze.
    Cao BJ, Rodgers RJ.
    Neuropharmacology; 1997 Aug; 36(8):1089-97. PubMed ID: 9294974
    [Abstract] [Full Text] [Related]

  • 19. Effect of orally administered misoprostol and cimetidine on the steady state pharmacokinetics of diazepam and nordiazepam in human volunteers.
    Lima DR, Santos RM, Werneck E, Andrade GN.
    Eur J Drug Metab Pharmacokinet; 1991 Aug; 16(3):161-70. PubMed ID: 1814733
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.